Codrituzumab (Anti-GPC3 / Glypican-3)
Codrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2476 |
| Sku # | A2476-1mg*25 |
| Pricing | 1mg*25, $2370.00 |